[ NKCL participates as an anchor company in the Chungbuk Advanced Regenerative Bio Global Innovation Special Zone project ]
In establishing a business plan for "Designation of Chungbuk Advanced Regenerative Bio Global Innovation Special Zone" announced last December, on January 19th, hosted by the Chungbuk Free Economic Zone Authority (Director Maeng Gyeong-kyeong), relevant ministries, leading domestic bio companies and advanced regenerative medicine were implemented. A business information session was held with the participation of organizations.
NKCL Bio Group works with large pharmaceutical companies
It is classified as an anchor company in the special zone and is participating in this project.
As a representative of a participating bio company on the day, I received a lot of attention and encouragement as I was able to suggest the direction of the business.
It is expected that cell therapy procedures will soon be implemented in Korea due to the business development of this global innovation special zone.
**What is an anchor company?
It refers to a company that plays a leading role in local business, such as a specific industry or special zone. It usually has a high market share in the industry, has excellent technology and capital, and has a positive impact on the local community.
In the case of Chungbuk Global Innovation Special Zone
Together with large pharmaceutical companies that have already become unicorn companies
It is meaningful to select an anchor company as a company with the potential to grow into a unicorn company in the future.
